Fecal calprotectin in healthy children

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 74, Issue 3, 2014, Pages 254-258

  Oord, Tonje ^a   Hornung, Nete ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b RANDERS REGIONAL HOSPITAL   (Denmark)

Author keywords

Calprotectin; Child; Feces; Inflammatory bowel disease; Reference values

Indexed keywords

CALGRANULIN;

ANUS FISSURE; ARTICLE; CHILD; COLORECTAL CANCER; COLORECTAL POLYP; CONCENTRATION (PARAMETERS); FALSE NEGATIVE RESULT; FECES; FEMALE; GASTROENTERITIS; GROUPS BY AGE; HEMORRHOID; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFANT; NEWBORN; PRESCHOOL CHILD; REFERENCE VALUE;

CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; REFERENCE VALUES;

EID: 84898457176     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2013.879732     Document Type: Article

References (22)

1. Fagerhol MK, Dale I, Andersson T. Release and quantitiation of a leucocyte derived protein (L1). Scan J Haematol 1980;24:393-8
2. Fagerhol MK, Andersson KB, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leucoyte protein). In: Smith VL, Dedman JR, eds. stimulus response coupling: The role of intracellular calcium binding proteins. Boca Raton, FL: CRC Press; 1990;187-210
3. Dale I, Brandtzaeg P, Fagerhol MK, Scott H. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofl uorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol 1985;84:24-34
4. Johne B, Fagerhol M K, Lyberg T, Prydz H, Brandtzaeg P, Naess-Andresen CF, Dale I. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol 1997;50:113-23
5. Roseth A G, Kristinsson J, Fagerhol MK, Schjonsby H, Aadland E, Nygaard K, Roald B. Faecal calprotectin: A novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 1993;28:1073-6
6. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, Bjarnason I. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-6
7. Roseth AG, Fagerhol M K, Aadland E, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. Amethodologic study. Scand J Gastroenterol 1992;27:793-8
8. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, agranulocyte marker protein, in patients with infl ammatory bowel disease. Scand J Gastroenterol 1999;34:50-4
9. Roseth A G, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, anovel granulocyte marker protein. Digestion 1997;58:176-80
10. Bunn S K, Bisset W M, Main M J, Golden B E. Fecal calprotectin as a measure of disease activity in childhood infl ammatory bowel disease. JPediatr Gastroenterol Nutr 2001;32:171-7
11. Kostakis I D, Cholidou K G, Vaiopoulos AG, Vlachos I S, Perrea D, Vaos G. Fecal calprotectin in pediatric infl ammatory bowel disease: A systematic review. Dig Dis Sci 2013;58:309-19
12. Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y. Colorectal infl ammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr 2005;40:450-5
13. Ton H, Brandsnes, Dale S, Holtlund J, Skuibina E, Schjonsby H, Johne B. Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41-54
14. Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, Pesce A, Sine HE, Zakowski J. Defi ning, establishing, and verifying reference intervals in the clinical laboratory; approved guideline-3rd ed. 2008;28
15. Rugtveit J, Fagerhol MK. Age-dependent variations in fecal calprotectin concentrations in children. JPediatr Gastroenterol Nutr 2002;34 :323,4; author reply 324-5
16. Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with infl ammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002;91:45-50
17. Rhoads J M, Fatheree N Y, Norori J, Liu Y, Lucke J F, Tyson JE, Ferris MJ. Altered fecal microfl ora and increased fecal calprotectin in infants with colic. JPediatr 2009;155:823-8
18. Nissen AC, van Gils C E, Menheere P P, Van den Neucker AM, van der Hoeven MA, Forget PP. Fecal calprotectin in healthy term and preterm infants. JPediatr Gastroenterol Nutr 2004;381:107-8
19. Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. Faecal calprotectin in term and preterm neonates. JPediatr Gastroenterol Nutr 2010;51:542-7
20. Fagerberg U L, Loof L, Merzoug R D, Hansson LO, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. JPediatr Gastroenterol Nutr 2003;37:468-72
21. Henderson P, Anderson NH, Wilson DC. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric infl ammatory bowel disease: A systematic review and meta-Analysis. Am J Gastroenterol 2012;107:941-9
22. Chen CC, Huang JL, Chang CJ, Kong MS. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. JPediatr Gastroenterol Nutr 2012;55:541-7